Sleep Medicine Reviews
Volume 6, Issue 5 , Pages 341-351 , October 2002

Neurobiological bases for the relation between sleep and depression

  • Joëlle Adrien

      Affiliations

    • Correspondence should be addressed to: Dr Joëlle Adrien; Tel:33140779713; Fax: 33140779790; E-mail:adrien@ext.jussieu.fr

References 

  1. Dahlström A, Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in cell bodies of brain stem neurons. Acta Physiol Scand. 1964;232:S1–S55
  2. Tork I. Anatomy of the serotoninergic system. Ann NY Acad Sci. 1990;600:9–35
  3. Pineyro G, Blier P. Autoregulation of serotonin neurons: role on antidepressant drug action. Pharmacol Rev. 1999;51:533–591
  4. VanderMaelen CP, Aghajanian GK. Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res. 1983;289:109–119
  5. Adrien J. The serotoninergic system and sleep- wakefulness regulations. In:  Kales A editors. Pharmacology of sleep, Handbook of Experimental Pharmacology. 116:Berlin: Springer-Verlag; 1995;p. 91–116
  6. Trulson MH, Jacobs BL. Raphe unit activity in freely moving cats: correlation with level of behavioral arousal. Brain Res. 1979;163:135–150
  7. Guzmàn-Marin R, Alam MN, Szymuziak R, Drucker- Colin R, Gong H, McGinty D. Discharge modulation of rat dorsal raphe neurons during sleep and waking: effects of preoptic/basal forebrain warming. Brain Res. 2000;875:23–34
  8. Portas CM, Bjorvatn B, Ursin R. Serotonin and the sleep/wake cycle: special emphasis on microdialysis studies. Progr Neurobiol. 2000;60:13–35
  9. Tissier MH, Lainey E, Fattaccini CM, Hamon M, Adrien J. Effects of ipsapirone, a 5-HT1A agonist, on sleep-wakefulness cycles: probable post-synaptic action. J Sleep Res. 1993;2:103–109
  10. Gervasoni D, Peyron C, Rampon C, Barbagli B, Chouvet G, Urbain N. Role and origin of the GABAergic innervation of Dorsal Raphe serotoninergic neurons. J Neurosci. 2000;20:4217–4225
  11. Ursin R. Serotonin and sleep. Sleep Med Rev. 2002;6:55–67
  12. Dugovic C, Wauquier A, Leysen J, Marrannes R, Janssen P. Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat. Psychopharmacology. 1989;97:436–442
  13. Boutrel B, Franc B, Hen R, Hamon M, Adrien J. Key role of 5-HT1B receptors in the regulation of paradoxical sleep, as evidenced in 5-HT1B knock-out mice. J Neuroscience. 1999;19:3204–3212
  14. Boutrel B, Monaca C, Hen R, Hamon M, Adrien J. Involvement of 5-HT1A receptors in homeostatic and stress-induced adaptive regulations of paradoxical sleep: studies in 5-HT1A knock-out mice. J Neurosci. 2002;
  15. Sakai C, Crochet S. Role of dorsal raphe neurons in paradoxical sleep generation in the cat: no evidence for a serotonergic mechanism. Eur J Neurosci. 2001;13:103–112
  16. Horner R, Sanford L, Annis A, Pack A, Morrison A. Serotonin at the laterodorsal tegmental nucleus suppresses rapid eye movement sleep in freely behaving rats. J Neurosci. 1997;17:7541–7552
  17. Thakkar M, Strecker R, McCarley R. Behavioral state control through differential serotoninergic inhibition in the mesopontine cholinergic nuclei: a simultaneous unit recording and microdialysis study. J Neurosci. 1998;18:5490–5497
  18. Kupfer DJ. REM latency: a psychobiological marker for primary depressive disease. Biol Psychiatry. 1975;11:159–174
  19. Benca RM, Obermeyer WH, Thisted RA, Gillin JC. Sleep and psychiatric disorders: a meta-analysis. Arch Gen Psychiatry. 1992;49:651–668
  20. Diagnostic and Coding Manual. Rochester: American Sleep Disorders Association; 1990;
  21. Vogel GW, Buffenstein A, Minter K, Hennessey A. Drug effects on REM sleep and on endogenous depression. Neurosci Biobehav Rev. 1990;14:49–63
  22. Steriade M, McCarley R. REM sleep as a biological rhythm. In:  Steriade M,  Mc Carley R editor. Brainstem control of wakefulness and sleep. New York: Plenum Press; 1990;p. 363–393
  23. Gillin JC, Sutton L, Ruiz C, Kelsoe J, Dupont RM, Darko D. The cholinergic rapid eye movement induction test with arecoline in depression. Arch Gen Psychiatry. 1991;48:264–270
  24. Maes M, Meltzer HY. The serotonin hypothesis of major depression. In:  Bloom FE,  Kupfer DJ editor. Psychopharmacology: The fourth generation of progress. New York: Raven Press; 1995;p. 933–944
  25. Lauriello J, Kenny WM, Sutton L, Golshan S, Ruiz C, Kelsoe J. The cholinergic REM sleep induction test with pilocarpine in midly depresses patients and normal controls. Biol Psychiatry. 1993;33:33–39
  26. Siefritz E, Gillin JC, Rapaport MH, Kelsoe JR, Bhatti T, Stahl SM. Sleep electroencephalographic response to muscarinic and serotonin1A receptor probes in patients with major depression and in normal controls. Biol Psychiatry. 1998;44:21–33
  27. Adrien J, Dugovic C, Martin P. Sleep-wakefulness patterns in the helpless rat. Physiol Behav. 1991;49:257–262
  28. Vogel GW, Neill D, Kors D, Hagler M. REM sleep abnormalities in a new animal model of endogenous depression. Neurosci Biobehav Rev. 1990;14:77–83
  29. Dugovic C, Maccari S, Weibel L, Turek FW, Van Reeth O. High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations. J Neurosci. 1999;19:8656–8664
  30. Boutrel B, Pardon MC, Joubert C, Barden N, Hamon M, Cohen-Salmon C. Different courses of Paradoxical Sleep (PS) rebound after PS deprivation or immobilization stress. J Sleep Res. 2000;9:25
  31. Pflug B, Tölle R. Disturbance of the 24-hour-rythm in endogenous depression and the treatment of endogenous depression by sleep deprivation. Int Pharmacopsychiatry. 1971;6:187–196
  32. Wu JC, Bunney WE. The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry. 1990;147:14–21
  33. Wirz-Justice A, Van den Hoofdakker RH. Sleep deprivation in depression: what do we know, where do we go?. Biol Psychiatry. 1999;46:445–453
  34. Southmayd SE, Michela MD, Cairns J, Delva NJ, Letemendia FJ, Waldron JJ. Sleep deprivation in depression; pattern of relapse and characteristics of preceding sleep. Biol Psychiatry. 1990;28:979–988
  35. Vogel GW, Vogel F, Mc Abee RS, Thurmond AJ. Improvement of depression by REM sleep deprivation, new findings and a theory. Arch Gen Psychiatry. 1980;37:247–253
  36. Van den Hoofdakker RH. Total sleep deprivation: clinical and theoretical aspects. In:  Honig AV,  Praag HM editor. Depression: Neurobiological, psychopathogical and therapeutic advances. Chichester: John Wiley & Sons; 1997;p. 564–589
  37. Adrien J. Antidepressant-like effects of paradoxical sleep deprivation in the learned helplessness paradigm. J Sleep Res. 1992;1:2
  38. Koolhass JM, Hermann PM, Kemperman C, Bohus B, Van den Hoofdakker RH, Beersma DGM. Single social defeat in male rats induces a gradual but long lasting behavioural change: a model of depression. Neurosci Res Comm. 1990;7:35–41
  39. Prathiba J, Kumar KB, Karanth KS. Effects of REM sleep deprivation on cholinergic receptor sensitivity and passive avoidance behaviour in chlomipramine model of depression. Brain Res. 2000;867:243–245
  40. Janowsky DS, Davis JM, El-Yousef MK, Sekerke HJ. A cholinergic-adrenergic hypothesis of mania and depression. Lancet. 1972;2:632–635
  41. Kapitany T, Schindl M, Schindler SD, Hesselmann B, Fureder T, Barnas C. The citalopram challenge test in patients with major depression and healthy controls. Psychiatry Res. 1999;88:75–88
  42. Staley JK, Malison RT, Innis RB. Imaging of the serotoninergic system: interactions of neuroanatomical and functional abnormalities of depression. Biol Psychiatry. 1998;44:534–549
  43. Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci. 1998;18:7394–7401
  44. Ogilvie A, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwim GM. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet. 1996;347:731–737
  45. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. Serotonin function and the mechanism of antidepressant action. Arch Gen Psychiatry. 1990;47:411–418
  46. Moore P, Landholt H, Seifritz E, Clark C, Bhatti T, Kelsoe J. Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology. 2000;23:601–622
  47. Maudhuit C, Prévot E, Dangoumau L, Martin P, Hamon M, Adrien J. Antidepressant treatment in helpless rats: Effect on the electrophysiological activity of raphe dorsalis serotoninergic neurons. Psychopharmacology. 1997;130:269–275
  48. Blier P, de Montigny C, Chaput Y. Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. J Clin Psychopharmacol. 1987;7:24S–35S
  49. Bel N, Artigas F. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse. 1993;15:243–245
  50. Hjorth S, Bengtsson HJ, Kullberg A, Carlzon D, Peilot H, Auerbach SB. Serotonin autoreceptor function and antidepressant drug action. J Psychopharmacol. 2000;14:177–185
  51. Chaput Y, Blier P, de Montigny C. Acute and long-term effects of antidepressant serotonin (5-HT) reuptake blockers on the efficacy of 5-HT neurotransmission: electrophysiological studies in the rat central nervous system. Adv Biol Psychiatry. 1988;17:1–17
  52. Jolas T, Haj-Dahmane S, Kidd EJ, Langlois X, Lanfumey L, Fattacini CM. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine. J Pharm Exp Ther. 1994;268:1432–1443
  53. Maudhuit C, Hamon M, Adrien J. Effects of chronic treatment with zimelidine and REM sleep deprivation on the regulation of raphe neuronal activity in a rat model of depression. Psychopharmacology. 1996;124:267–274
  54. Artigas F, Perez V, Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry. 1994;51:248–251
  55. Blier P, Bergeron R. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Pharmacol. 1995;15:217–222
  56. Artigas F, Romero L, de Montigny C, Blier P. Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends Neuro Sci. 1996;19:378–383
  57. Dannon PN, Sasson Y, Hirschmann S, Ianeu I, Grunhaus LJ, Zohar J. Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial. Eur Neuropsychopharmacol. 2000;10:165–169
  58. Montgomery SA. New developments in the treatment of depression. J Clin Psychopharmacol. 1999;60:10–15
  59. Rabiner EA, Gunn RN, Wilkins MR, Sargent PA, Mocaer E, Sedman E. Drug action at the 5-HT1A receptor in vivo: autoreceptor and postsynaptic receptor occupancy examined with PET and [carbonyl-(11)C]WAY-100635. Nucl Med Biol. 2000;27:509–513
  60. Berman RM, Anand A, Cappiello A, Miller HL, Hu XS, Oren DA. The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial. Biol Psychiatry. 1999;45:1170–1177
  61. Rasanen P, Hakko H, Tihonen J. Pindolol and major affective disorders: a three-year follow-up study of 30,485 patients. J Clin Psychopharmacol. 1999;19:383–384
  62. Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M. Polymorphism within the promotor of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry. 1998;3:508–511
  63. Benedetti F, Seretti A, Colombo C, Campori E, Barbini B, di Bella D. Infuence of a functional polymorphism within the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression. Am J Psychiatry. 1999;156:1450–1452
  64. Siefritz E, Muller MJ, Annen O, Nil R, Hatzinger M, Hemmeter U. Effect of sleep deprivation on neuroendocrine response to a serotonergic probe in healthy male subjects. J Psychiatr Res. 1997;31:543–554
  65. Maudhuit C, Jolas T, Chastanet M, Hamon M, Adrien J. Reduced inhibitory potency of 5-HT reuptake blockers on central serotoninergic neurons in rats selectively deprived of rapid eye movement sleep. Biol Psychiatry. 1996;40:1000–1007
  66. Prévot E, Maudhuit C, Le Poul E, Hamon M, Adrien J. Sleep deprivation reduces the citalopram-induced inhibition of serotoninergic neuronal firing in the nucleus raphe dorsalis of the rat. J Sleep Res. 1996;5:238–245
  67. Gardner JP, Fornal CA, Jacobs BL. Effects of sleep deprivation on serotoninergic neuronal activity in the dorsal raphe nucleus of the freely movint cat. Neuropsychopharmacology. 1997;17:72–81
  68. Smeraldi E, Benedetti F, Barbini B, Campori E, Colombo C. Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression. A placebo-controlled trial. Neuropsychopharmacology. 1999;20:380–385
  69. Benedetti F, Barbini B, Campori E, Colombo C, Smeraldi E. Dopamine agonist amineptine prevents the antidepressant effect of sleep deprivation. Psychiatry Res. 1996;65:179–184
  70. Leibenluft E, Wehr TA. Is sleep deprivation useful in the treatment of depression?. Am J Psychiatry. 1992;149:159–168
  71. Benedetti F, Barbini B, Lucca A, Campori E, Colombo C, Smeraldi E. Sleep deprivation hastens the antidepressant action of fluoxetine. Eur Arch Psychiatry Clin Neurosci. 1997;247:100–103
  72. Post RM, Weiss SR. Endogenous biochemical abnormalities in affective illness: therapeutic versus pathogenic. Biol Psychiatry. 1992;32:469–484
  73. Ebert D, Berger M. Neurobiological similarities in antidepressant sleep deprivation and psychostimulant use: a psychostimulant theory of antidepressant sleep deprivation. Psychopharmacology. 1998;140:1–10
  74. Giles DE, Kupfer DJ, Rush AJ, Roffwarg HP. Controlled comparison of electrophysiological sleep in families of probands with unipolar depression. Am J Psychiatry. 1998;155:192–199
  75. Gillin JC. Are sleep disturbance risk factors for anxiety, depressive and addictive disorders?. Acta Psychiatr Scand. (Suppl.). 1998;393:39–43
  76. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?. JAMA. 1989;262:1479–1484
  77. Benca RM. Consequences of insomnia and its therapies. J Clin Psychiatry. 2001;62:33–38
  78. Viot-Blanc V. To sleep more or to sleep less to get a better mood?. J Sleep Res. 1996;5:244

PII: S1087-0792(01)90200-X

doi: 10.1053/smrv.2001.0200

Sleep Medicine Reviews
Volume 6, Issue 5 , Pages 341-351 , October 2002

Article Tools